CaixaBank, S.A.’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.8M Buy
74,906
+2,654
+4% +$2.01M 0.25% 81
2026
Q2
$45.1M Sell
72,252
-25,985
-26% -$17.7M 0.21% 89
2026
Q1
$75.9M Buy
98,237
+13,742
+16% +$10.5M 0.41% 57
2025
Q4
$65.2M Sell
84,495
-15,372
-15% -$10.4M 0.33% 63
2025
Q3
$56.2M Sell
99,867
-17,596
-15% -$9.9M 0.28% 66
2025
Q2
$61.7M Sell
117,463
-72,752
-38% -$40.6M 0.32% 64
2025
Q1
$121M Sell
190,215
-35,594
-16% -$24.5M 0.7% 41
2024
Q4
$161M Buy
225,809
+46,475
+26% +$39M 0.85% 32
2024
Q3
$189M Sell
179,334
-14,821
-8% -$16.5M 1.03% 25
2024
Q2
$204M Buy
194,155
+1,451
+0.8% +$1.41M 1.16% 18
2024
Q1
$185M Buy
192,704
+16,959
+10% +$16.1M 1.1% 23
2023
Q4
$154M Buy
175,745
+804
+0.5% +$662K 1.06% 30
2023
Q3
$144M Sell
174,941
-16,410
-9% -$12.9M 1.11% 28
2023
Q2
$137M Buy
191,351
+1,025
+0.5% +$790K 1.02% 31
2023
Q1
$156M Sell
190,326
-9,388
-5% -$7.08M 1.26% 24
2022
Q4
$144M Buy
199,714
+44,345
+29% +$32.7M 1.2% 24
2022
Q3
$107M Sell
155,369
-41,876
-21% -$26.4M 0.94% 30
2022
Q2
$117M Buy
197,245
+34,042
+21% +$22.1M 1.05% 27
2022
Q1
$114M Buy
163,203
+38,467
+31% +$24.3M 0.93% 28
2021
Q4
$78.8M Buy
124,736
+25,651
+26% +$15.8M 0.64% 40
2021
Q3
$60M Buy
99,085
+40,090
+68% +$24.9M 0.54% 47
2021
Q2
$33M Buy
58,995
+45,089
+324% +$22.8M 0.3% 69
2021
Q1
$6.58M Buy
13,906
+13,663
+5,623% +$6.65M 0.07% 202
2020
Q4
$117K Buy
+243
New +$131K ﹤0.01% 407
2019
Q3
– Sell
-25,801
Closed -$8.08M – 369
2019
Q2
$8.08M Sell
25,801
-1,408
-5% -$469K 0.18% 171
2019
Q1
$11.2M Buy
27,209
+24,387
+864% +$10M 0.26% 110
2018
Q4
$1.02M Sell
2,822
-1,016
-26% -$372K 0.03% 202
2018
Q3
$1.55M Sell
3,838
-33,172
-90% -$12.6M 0.04% 196
2018
Q2
$12.8M Sell
37,010
-28,760
-44% -$8.99M 0.41% 54
2018
Q1
$22.6M Buy
+65,770
New +$22.9M 0.76% 28

Other funds holding REGN

CaixaBank, S.A.'s REGN Position: Q3 2026 in Review

CaixaBank, S.A. increased its Regeneron Pharmaceuticals (REGN) stake by 3.7% in Q3 2026, buying an estimated $2.01M and bringing the position to 74,906 shares worth $56.8M. The position accounts for 0.25% of the portfolio, ranked #81.

CaixaBank, S.A. first reported a position in REGN in Q1 2018 and has held it in 30 quarters since. The position peaked at $204M in Q2 2024. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • CaixaBank, S.A. held 74,906 shares of Regeneron Pharmaceuticals worth $56.8M as of Q3 2026.
  • CaixaBank, S.A. bought 2,654 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $2.01M.
  • Regeneron Pharmaceuticals made up 0.25% of CaixaBank, S.A.'s portfolio in Q3 2026, its #81 holding.
  • CaixaBank, S.A. first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 30 quarters since.
  • CaixaBank, S.A.'s Regeneron Pharmaceuticals position peaked at $204M in Q2 2024.
  • 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.